Retail

FDA recalls clams, raw oysters over potential norovirus across 9 states

The FDA has issued a recall for clams and raw oysters over a possible norovirus contamination, with shellfish distributed to restaurants and retailers in nine states: Arizona, California, Florida, Georgia, Illinois, Nevada, New York, Oregon and Washington. Washington State Department of Health is coordinating the recall with the FDA, and customers should stop serving the products and arrange disposal or destruction via the distributor.

📅 March 09, 2026
⏱️ 2 min read
FDA recalls clams, raw oysters over potential norovirus across 9 states

Key Takeaways

  • FDA recall issued for clams and raw oysters over potential norovirus contamination.
  • Clams from Lummi Indian Business Council; oysters from Drayton Harbor Oyster Company; WA origins.
  • Harvest window reported as Feb 13–Mar 3, 2026 (inferred) with WA-based sources.
  • Restaurants and retailers must discard recalled shellfish or arrange destruction via distributor.

People Involved

  • No specific individuals mentioned

Entities Involved

  • Lummi Indian Business Council Clams supplier (Washington)
  • Drayton Harbor Oyster Company Oysters supplier (Washington)
  • Washington State Department of Health State health authority coordinating the recall with FDA
  • FDA Federal agency issuing the recall notice

MarketMoodz Analysis

This recall underscores a material public-health risk and a potential supply-chain disruption for seafood retailers and restaurants. If recalled shellfish remain in inventory, operators face disposal or destruction costs, potential spoilage, and reputational exposure, while suppliers may need to reroute stock and adjust pricing.

Historically, FDA recalls of shellfish tied to norovirus have prompted heightened inspections, facility audits, and tighter vendor controls. Investors should monitor FDA and state health updates for distribution-level details, as new lots or harvest origins could emerge and alter risk assessments.

Source: Original Article

Get AI-Powered Market Insights

Stay ahead of market-moving events with our real-time analysis and stock ratings.

Start Your Free Trial